Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor 5-HT4 is a G protein-coupled receptor that mediates various physiological processes in both the central and peripheral nervous systems. It is involved in neurotransmitter modulation, regulation of gastrointestinal motility, and modulation of appetite and feeding behavior. Clinically, it is targeted by drugs such as prucalopride, renzapride, and felcisetrag to treat conditions like chronic idiopathic constipation and constipation-predominant IBS.
Agonist of 5-HT4 receptor, stimulating intestinal peristalsis via activation of enteric neuronal circuits.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT4 (5-HT4).